Literature DB >> 11793119

Molecular and cellular defects in nephrogenic diabetes insipidus.

N V Knoers1, P M Deen.   

Abstract

The identification of the different molecular causes of congenital nephrogenic diabetes insipidus (NDI), a disorder characterized by renal insensitivity to the antidiuretic effect of arginine vasopressin, has been of indispensable importance for understanding the cellular processes involved in diuresis and antidiuresis. In most cases, NDI is X-linked and caused by mutations in the vasopressin type-2 receptor (V2R) gene. Mutations in the aquaporin-2 (AQP2) water channel gene are responsible for the autosomal recessive and rare dominant forms of NDI. By in vitro expression, it has been shown that the majority of V2R mutants and all AQP2 mutants found in recessive NDI are misfolded and retained within the endoplasmic reticulum (ER). Functional analysis of one of the mutations identified in dominant NDI showed that this mutant is properly folded and transported out of the ER, but is retained in the Golgi region. In addition, this mutant, in contrast to mutants found in recessive NDI, is able to heterotetramerize with wild-type AQP2. The resulting complex is hindered in its transport to the membrane, a finding that explains the dominant-negative effect of this mutation. Several new methodologies focused on the molecular defects causing NDI are presently being investigated in vitro and might eventually develop into useful therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11793119     DOI: 10.1007/s004670100051

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.

Authors:  Duygu Duzenli; Emel Saglar; Ferhat Deniz; Omer Azal; Beril Erdem; Hatice Mergen
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 2.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

3.  Pediatric disorders of water balance.

Authors:  Sayali A Ranadive; Stephen M Rosenthal
Journal:  Pediatr Clin North Am       Date:  2011-10       Impact factor: 3.278

4.  A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.

Authors:  Akira Ashida; Daisuke Yamamoto; Hyogo Nakakura; Hideki Matsumura; Shinichi Uchida; Sei Sasaki; Hiroshi Tamai
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

5.  Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.

Authors:  Sayali A Ranadive; Baran Ersoy; Helene Favre; Clement C Cheung; Stephen M Rosenthal; Walter L Miller; Christian Vaisse
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-18       Impact factor: 3.478

6.  Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation.

Authors:  Pui W Cheung; Abby Terlouw; Sam Antoon Janssen; Dennis Brown; Richard Bouley
Journal:  J Physiol       Date:  2018-12-21       Impact factor: 5.182

7.  Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.

Authors:  Baoxue Yang; Dan Zhao; A S Verkman
Journal:  FASEB J       Date:  2008-10-14       Impact factor: 5.191

8.  Two novel mutations in the aquaporin 2 gene in a girl with congenital nephrogenic diabetes insipidus.

Authors:  Hae Il Cheong; Su Jin Cho; Shou Huan Zheng; Hee Yeon Cho; Il Soo Ha; Yong Choi
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

Review 9.  Pediatric disorders of water balance.

Authors:  Sayali A Ranadive; Stephen M Rosenthal
Journal:  Endocrinol Metab Clin North Am       Date:  2009-12       Impact factor: 4.741

10.  Long-term growth of children with nephrogenic diabetes insipidus.

Authors:  Horacio Lejarraga; Maria Gracia Caletti; Silvia Caino; Alejandra Jiménez
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.